$SAGE Sage Therapeutics, Inc. Insider Trading Week 20/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sage Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sage Therapeutics, Inc. in week 20/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 40,356 | 18,160 | 127,723 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Option Exercise | M | 0.45 | 53,908 | 24,259 | 168,079 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 177.76 | 950 | 168,872 | 62,115 | 63.1 K to 62.1 K (-1.51 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.80 | 2,518 | 445,182 | 63,065 | 65.6 K to 63.1 K (-3.84 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.79 | 3,974 | 698,589 | 65,583 | 69.6 K to 65.6 K (-5.71 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.02 | 24,966 | 4,369,549 | 69,557 | 94.5 K to 69.6 K (-26.41 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.05 | 7,948 | 1,383,349 | 94,523 | 102.5 K to 94.5 K (-7.76 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 40,356 | 18,160 | 102,471 | 62.1 K to 102.5 K (+64.97 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 176.15 | 1,763 | 310,552 | 62,115 | 63.9 K to 62.1 K (-2.76 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 175.09 | 14,727 | 2,578,550 | 63,878 | 78.6 K to 63.9 K (-18.74 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 174.46 | 31,099 | 5,425,532 | 78,605 | 109.7 K to 78.6 K (-28.35 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 173.41 | 4,200 | 728,322 | 109,704 | 113.9 K to 109.7 K (-3.69 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 172.20 | 1,619 | 278,792 | 113,904 | 115.5 K to 113.9 K (-1.40 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Sell | S | 171.01 | 500 | 85,505 | 115,523 | 116 K to 115.5 K (-0.43 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | JONAS JEFFREY M | President & CEO | Buy | M | 0.45 | 53,908 | 24,259 | 116,023 | 62.1 K to 116 K (+86.79 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Option Exercise | M | 73.43 | 25,000 | 1,835,750 | 160,000 | |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Sell | S | 175.00 | 25,000 | 4,375,000 | 461 | 25.5 K to 461 (-98.19 %) |
May 24 2019 | SAGE | Sage Therapeutics, ... | Cloonan Michael | Chief Business Offi ... | Buy | M | 73.43 | 25,000 | 1,835,750 | 25,461 | 461 to 25.5 K (+5,422.99 %) |